Literature DB >> 19026145

Mortality in psoriatic arthritis.

D D Gladman1.   

Abstract

Psoriatic arthritis has been demonstrated to be a severe form of arthritis in a proportion of patients. Progression of joint damage has been noted even within the first 2 years of disease in almost half the patients. Polyarticular presentation, disease activity, and damage predict progression of joint damage. An increased mortality was reported from large studies of 428 and 680 patients with psoriatic arthritis. Cardiovascular-related disease is the most common cause of death, followed by respiratory diseases, cancer, and injuries and poisoning. Deaths from respiratory disease, cardiovascular disease, and injuries and poisoning were found to be higher than those in the general population. Predictors for mortality include a high sedimentation rate and radiological damage at presentation. Since disease activity is associated with progression of damage, and damage predicts mortality, it is important to treat patients aggressively to prevent these outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 19026145

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  26 in total

1.  Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.

Authors:  Alexis Ogdie; Samantha Maliha; Daniel Shin; Thorvardur Jon Love; Joshua Baker; Yihui Jiang; Hyon Choi; Joel M Gelfand
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

2.  Is remission a more realistic goal in psoriatic arthritis?

Authors:  Tajvur P Saber; Ursula Fearon; Douglas J Veale
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

3.  Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study.

Authors:  F C Ernste; M Sánchez-Menéndez; K M Wilton; C S Crowson; E L Matteson; H Maradit Kremers
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

Review 4.  Managing premature atherosclerosis in patients with chronic inflammatory diseases.

Authors:  Alexandra Legge; John G Hanly
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

5.  Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Authors:  Jasvinder A Singh; Gordon Guyatt; Alexis Ogdie; Dafna D Gladman; Chad Deal; Atul Deodhar; Maureen Dubreuil; Jonathan Dunham; M Elaine Husni; Sarah Kenny; Jennifer Kwan-Morley; Janice Lin; Paula Marchetta; Philip J Mease; Joseph F Merola; Julie Miner; Christopher T Ritchlin; Bernadette Siaton; Benjamin J Smith; Abby S Van Voorhees; Anna Helena Jonsson; Amit Aakash Shah; Nancy Sullivan; Marat Turgunbaev; Laura C Coates; Alice Gottlieb; Marina Magrey; W Benjamin Nowell; Ana-Maria Orbai; Soumya M Reddy; Jose U Scher; Evan Siegel; Michael Siegel; Jessica A Walsh; Amy S Turner; James Reston
Journal:  Arthritis Rheumatol       Date:  2018-11-30       Impact factor: 10.995

Review 6.  Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Authors:  Jasvinder A Singh; Gordon Guyatt; Alexis Ogdie; Dafna D Gladman; Chad Deal; Atul Deodhar; Maureen Dubreuil; Jonathan Dunham; M Elaine Husni; Sarah Kenny; Jennifer Kwan-Morley; Janice Lin; Paula Marchetta; Philip J Mease; Joseph F Merola; Julie Miner; Christopher T Ritchlin; Bernadette Siaton; Benjamin J Smith; Abby S Van Voorhees; Anna Helena Jonsson; Amit Aakash Shah; Nancy Sullivan; Marat Turgunbaev; Laura C Coates; Alice Gottlieb; Marina Magrey; W Benjamin Nowell; Ana-Maria Orbai; Soumya M Reddy; Jose U Scher; Evan Siegel; Michael Siegel; Jessica A Walsh; Amy S Turner; James Reston
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11-30       Impact factor: 4.794

Review 7.  Management of psoriatic arthritis from the view of the dermatologist.

Authors:  Caroline A Chang; Alice B Gottlieb; Paul F Lizzul
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

8.  Malignancy incidence in patients with psoriatic arthritis: a comparison cohort-based incidence study.

Authors:  Katelynn M Wilton; Cynthia S Crowson; Eric L Matteson
Journal:  Clin Rheumatol       Date:  2016-08-29       Impact factor: 2.980

9.  Clinicians' perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study.

Authors:  Daniel Sumpton; Elyssa Hannan; Ayano Kelly; David Tunnicliffe; Andrew Ming; Geraldine Hassett; Jonathan C Craig; Allison Tong
Journal:  Clin Rheumatol       Date:  2020-09-15       Impact factor: 2.980

10.  Remission in psoriatic arthritis: is it possible and how can it be predicted?

Authors:  Tajvur P Saber; C T Ng; Guillaume Renard; Bernadette M Lynch; Eliza Pontifex; Ceara A E Walsh; Alexia Grier; Marian Molloy; Barry Bresnihan; Oliver Fitzgerald; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2010-05-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.